Lv11
30 积分 2024-02-19 加入
Armored Bicistronic CAR T Cells with Dominant-negative TGF-β Receptor II to Overcome Resistance in Glioblastoma
3小时前
待确认
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
6小时前
已完结
Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique
7天前
已完结
Armored Bicistronic CAR T Cells with Dominant-negative TGF-β Receptor II to Overcome Resistance in Glioblastoma
21天前
已完结
Transgelin 2 guards T cell lipid metabolism and antitumour function
1个月前
已完结
Naturally occurring T cell mutations enhance engineered T cell therapies
1年前
已完结
皖公网安备34019202002308
